Sodium Chloride — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Sodium Chloride. We track 120 distinct Drug Identification Numbers (DINs) for this molecule, of which 20 are currently in marketed status. Across those registrations there are 18 manufacturers or marketing authorization holders, 4 dosage forms, and 42 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Sodium Chloride in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Sodium Chloride product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Sodium Chloride
Dosage forms: Solution, Liquid, Tablet, Powder For Solution. Strengths: 3.3 G, 5 G, 900 MG, 600 MG, 4.5 MG, 9 MG, 0.9 %, 0.9 G, 1.6 G, 10 %, 10 G, 6 DH, 12 G, 25 G.
Manufacturers and marketing authorization holders
BAXTER CORPORATION, B. BRAUN MEDICAL INC, FRESENIUS KABI CANADA LTD, HIKMA CANADA LIMITED, OMEGA LABORATORIES LIMITED, ABBOTT LABORATORIES, LIMITED, JUNO PHARMACEUTICALS CORP., LABORATORIOS GRIFOLS S.A., DOLISOS CANADA INC., BAXTER CORPORATION CLINTEC NUTRITION DIVISION, CLINTEC NUTRITION COMPANY, BIO AGRI MIX LP, ICU MEDICAL CANADA INC, KOOTENAY BORN BOTANICALS, BDH INC., ALTHIN BIOPHARM INC., GENPHARM ULC, WESTERN DIALYSIS SUPPLIES LTD..
Registered products containing Sodium Chloride
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 00438014 | (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 3.3 G | Solution | Marketed |
| 00786292 | (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 5 G | Solution | Marketed |
| 00786209 | (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 900 MG | Solution | Marketed |
| 00503142 | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 5 G | Solution | Cancelled Post Market |
| 00437999 | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 5 G | Solution | Marketed |
| 00786217 | (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 900 MG | Liquid | Marketed |
| 02246134 | (40 MMOLS/L) POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION USP | BAXTER CORPORATION | 600 MG | Solution | Cancelled Post Market |
| 00438022 | (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 3.3 G | Solution | Marketed |
| 00438006 | (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 5 G | Solution | Marketed |
| 01931741 | 0.15% POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.30% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | 3.3 G | Solution | Cancelled Post Market |
| 01931598 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 5 G | Solution | Marketed |
| 01931601 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.33% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 5 G | Liquid | Cancelled Post Market |
| 01931547 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | 5 G | Solution | Cancelled Post Market |
| 01931644 | 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | 5 G | Solution | Cancelled Post Market |
| 01931571 | 0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | 5 G | Solution | Cancelled Post Market |
| 01927949 | 0.45% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 4.5 MG | Solution | Marketed |
| 02395150 | 0.9% SODIUM CHLORIDE INJECTION | FRESENIUS KABI CANADA LTD | 900 MG | Solution | Marketed |
| 02304341 | 0.9% SODIUM CHLORIDE INJECTION USP | HIKMA CANADA LIMITED | 9 MG | Solution | Marketed |
| 02150204 | 0.9% SODIUM CHLORIDE INJECTION USP | OMEGA LABORATORIES LIMITED | 9 MG | Solution | Marketed |
| 01924303 | 0.9% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 0.9 % | Solution | Marketed |
| 02239576 | 0.9% SODIUM CHLORIDE INJECTION, USP | ABBOTT LABORATORIES, LIMITED | 0.9 G | Liquid | Cancelled Pre Market |
| 02538903 | 0.9% SODIUM CHLORIDE INJECTION, USP | JUNO PHARMACEUTICALS CORP. | 9 MG | Solution | Cancelled Pre Market |
| 00060208 | 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | 900 MG | Solution | Marketed |
| 02533537 | 0.9% SODIUM CHLORIDE INJECTION, USP | LABORATORIOS GRIFOLS S.A. | 0.9 % | Solution | Approved |
| 02530600 | 0.9% SODIUM CHLORIDE IRRIGATION USP | B. BRAUN MEDICAL INC | 0.9 % | Solution | Approved |
| 01963937 | 0.9% SODIUM CHLORIDE IRRIGATION USP | B. BRAUN MEDICAL INC | 0.9 % | Solution | Dormant |
| 00786160 | 0.9% SODIUM CHLORIDE IRRIGATION, USP | BAXTER CORPORATION | 900 MG | Solution | Marketed |
| 00783633 | 1.6% SODIUM CHLORDIE PROCESSING SOLUTION | BAXTER CORPORATION | 1.6 G | Solution | Cancelled Post Market |
| 01924206 | 10% DEXTRAN 40 IN 0.9% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | 10 % | Solution | Cancelled Post Market |
| 01927922 | 10% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 10 G | Solution | Cancelled Post Market |
| 02236458 | 12 SELS DE SCHUESSLER | DOLISOS CANADA INC. | 6 DH | Tablet | Cancelled Post Market |
| 00783625 | 12% SODIUM CHLORDIE PROCESSING SOLUTION | BAXTER CORPORATION | 12 G | Solution | Marketed |
| 02143267 | 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 10 G | Solution | Cancelled Post Market |
| 02013975 | 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 10 G | Solution | Cancelled Post Market |
| 02143259 | 2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX | CLINTEC NUTRITION COMPANY | 25 G | Liquid | Cancelled Post Market |
| 02143232 | 2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX | CLINTEC NUTRITION COMPANY | 25 G | Liquid | Cancelled Post Market |
| 02014009 | 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 170 MG | Solution | Cancelled Post Market |
| 02013991 | 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 5 G | Solution | Cancelled Post Market |
| 02143240 | 2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. | CLINTEC NUTRITION COMPANY | 137.5 MG | Liquid | Cancelled Post Market |
| 02514184 | 20% SODIUM CHLORIDE INJECTION, BP | BAXTER CORPORATION | 20 % | Solution | Marketed |
| 02245934 | 23.4% SODIUM CHLORIDE INJECTION USP | BAXTER CORPORATION | 23.4 % | Solution | Cancelled Post Market |
| 02270072 | 3 SULFA | BIO AGRI MIX LP | 170.5 G | Powder For Solution | Cancelled Pre Market |
| 00511757 | 3-SULVIT | BIO AGRI MIX LP | 170.5 G | Powder For Solution | Cancelled Post Market |
| 01927981 | 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 3.3 G | Solution | Dormant |
| 00038881 | 3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | 33.3 MG | Solution | Cancelled Post Market |
| 01924184 | 3% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 30 MG | Liquid | Cancelled Post Market |
| 02142414 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 10 G | Solution | Cancelled Post Market |
| 02142406 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 20 G | Solution | Cancelled Post Market |
| 02014033 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 20 G | Solution | Cancelled Post Market |
| 02142392 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 25 G | Solution | Cancelled Post Market |
| 02014017 | 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 5 G | Solution | Cancelled Post Market |
| 02143224 | 4.25%TRAVASOL AMINO ACID INJ.W.ELECW.5%DEX. | CLINTEC NUTRITION COMPANY | 5 G | Liquid | Cancelled Post Market |
| 01927558 | 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 5 G | Solution | Dormant |
| 00038873 | 5% DEXTROSE AND 0.225% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | 50 MG | Solution | Cancelled Post Market |
| 00038903 | 5% DEXTROSE AND 0.45% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | 50 MG | Solution | Dormant |
| 01927531 | 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 5 G | Solution | Marketed |
| 00038946 | 5% DEXTROSE AND 0.9% SODIUM CHLORIDE | ICU MEDICAL CANADA INC | 50 MG | Solution | Dormant |
| 01924435 | 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 50 MG | Solution | Marketed |
| 01931652 | 5% DEXTROSE IN LACTATED RINGER'S INJECTION | B. BRAUN MEDICAL INC | 5 G | Solution | Cancelled Post Market |
| 01928007 | 5% SODIUM CHLORIDE INJECTION USP | B. BRAUN MEDICAL INC | 5 G | Solution | Marketed |
| 02142368 | 5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | 20 G | Solution | Cancelled Post Market |
| 01924192 | 6% DEXTRAN 70 IN 0.9% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | 6 % | Solution | Cancelled Post Market |
| 02232047 | A LITTLE UNDERSTANDING | KOOTENAY BORN BOTANICALS | 30 X | Liquid | Cancelled Post Market |
| 00898287 | ACETATE CONCENTRATE R07318 LIQ | BDH INC. | 204.5 G | Liquid | Cancelled Post Market |
| 02179075 | ACETATE CONCENTRATE R07376 | BDH INC. | 204.5 G | Liquid | Cancelled Post Market |
| 00732656 | ACID CONCENTRATE D12028 | ALTHIN BIOPHARM INC. | 172 G | Liquid | Cancelled Post Market |
| 00732516 | ACID CONCENTRATE D12054 | ALTHIN BIOPHARM INC. | 172.2 G | Liquid | Cancelled Post Market |
| 00665657 | ACID CONCENTRATE D12092 | ALTHIN BIOPHARM INC. | 263 G | Solution | Cancelled Post Market |
| 00665665 | ACID CONCENTRATE D12093 | BAXTER CORPORATION | 263 G | Liquid | Cancelled Post Market |
| 00665681 | ACID CONCENTRATE D12095 | BAXTER CORPORATION | 263 G | Liquid | Cancelled Post Market |
| 00780006 | ACID CONCENTRATE D12119 | ALTHIN BIOPHARM INC. | 172 G | Liquid | Cancelled Post Market |
| 00792780 | ACID CONCENTRATE D12132 | ALTHIN BIOPHARM INC. | 172.2 G | Liquid | Cancelled Post Market |
| 00816663 | ACID CONCENTRATE D12150 | ALTHIN BIOPHARM INC. | 263 G | Liquid | Cancelled Post Market |
| 02158302 | ACID CONCENTRATE D12247 | ALTHIN BIOPHARM INC. | 263 G | Liquid | Cancelled Post Market |
| 02158272 | ACID CONCENTRATE D12250 | ALTHIN BIOPHARM INC. | 263 G | Liquid | Cancelled Post Market |
| 02158213 | ACID CONCENTRATE D12261 | ALTHIN BIOPHARM INC. | 3.35 G | Liquid | Cancelled Post Market |
| 02158116 | ACID CONCENTRATE D12268 | ALTHIN BIOPHARM INC. | 263 G | Liquid | Cancelled Post Market |
| 02231082 | ACID CONCENTRATE (R04146) | GENPHARM ULC | 184 G | Liquid | Cancelled Post Market |
| 00897787 | ACID CONCENTRATE (R04938) | GENPHARM ULC | 172.2 G | Liquid | Cancelled Post Market |
| 00869694 | ACID CONCENTRATE (R04968) | GENPHARM ULC | 180.8 G | Liquid | Cancelled Post Market |
| 00869708 | ACID CONCENTRATE (R04969) | GENPHARM ULC | 180.8 G | Liquid | Cancelled Post Market |
| 00869732 | ACID CONCENTRATE (R04974) | GENPHARM ULC | 172.2 G | Liquid | Cancelled Post Market |
| 00869740 | ACID CONCENTRATE (R04975) | GENPHARM ULC | 172.2 G | Liquid | Cancelled Post Market |
| 00869759 | ACID CONCENTRATE (R04976) | GENPHARM ULC | 172.2 G | Liquid | Cancelled Post Market |
| 00896969 | ACID CONCENTRATE (R04981) | GENPHARM ULC | 180.8 G | Liquid | Cancelled Post Market |
| 00897833 | ACID CONCENTRATE (R04984) | GENPHARM ULC | 172.2 G | Liquid | Cancelled Post Market |
| 02241924 | ACID CONCENTRATE (RO4147) | GENPHARM ULC | 182.9 G | Liquid | Cancelled Post Market |
| 02241925 | ACID CONCENTRATE (RO4148) | GENPHARM ULC | 184.0 G | Liquid | Cancelled Post Market |
| 00898430 | ACID CONCENTRATE (RO9503) | GENPHARM ULC | 214.8 G | Liquid | Cancelled Post Market |
| 02238182 | ACID CONCENTRATE (RZ262C) | GENPHARM ULC | 276.1 G | Liquid | Cancelled Post Market |
| 02238177 | ACID CONCENTRATE (RZ271C) | GENPHARM ULC | 262.98 G | Liquid | Cancelled Post Market |
| 02238178 | ACID CONCENTRATE (RZ272C) | GENPHARM ULC | 262.98 G | Liquid | Cancelled Post Market |
| 02238180 | ACID CONCENTRATE (RZ274C) | GENPHARM ULC | 274.81 G | Liquid | Cancelled Post Market |
| 02238181 | ACID CONCENTRATE (RZ275C) | GENPHARM ULC | 262.98 G | Liquid | Cancelled Post Market |
| 00774243 | ACID CONCENTRATE 2100 | BAXTER CORPORATION | 263 G | Solution | Cancelled Post Market |
| 00774790 | ACID CONCENTRATE 2101 | BAXTER CORPORATION | 263 G | Solution | Cancelled Post Market |
| 00774804 | ACID CONCENTRATE 2102 | BAXTER CORPORATION | 263 G | Solution | Cancelled Post Market |
| 00774839 | ACID CONCENTRATE 2105 | BAXTER CORPORATION | 262.98 G | Liquid | Cancelled Post Market |
| 02239609 | ACID CONCENTRATE 2106 | BAXTER CORPORATION | 263 G | Liquid | Cancelled Post Market |
| 00774871 | ACID CONCENTRATE 2109 | ALTHIN BIOPHARM INC. | 262.98 G | Liquid | Cancelled Post Market |
Sourcing Sodium Chloride through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Sodium Chloride we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Sodium Chloride and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.